Pharmacological treatment of reflex syncope

Clinical Autonomic Research

Volumn 14, Issue SUPPL. 1, 2004, Pages i71-i75

  Kaufmann, Horacio ^a   Freeman, Roy ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Alpha adrenoreceptor agonists; Beta adrenoreceptor antagonists; Orthostatic hypotension; Sympathetic nervous system parasympathetic nervous system; Syncope

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; ETILEFRINE; FLUDROCORTISONE; GLYCERYL TRINITRATE; MIDODRINE; N(G) METHYLARGININE; NADOLOL; NITRIC OXIDE SYNTHASE INHIBITOR; PAROXETINE; PROPRANOLOL; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANTICHOLINERGIC EFFECT; BODY POSITION; CLINICAL TRIAL; DIET THERAPY; DRUG EFFECT; DRUG EFFICACY; FATIGUE; FLUID INTAKE; FOLLOW UP; GLAUCOMA; HEAD TILTING; HUMAN; HYDRATION; HYPERTENSION; LONG TERM CARE; ORTHOSTATIC HYPOTENSION; PATIENT EDUCATION; QT PROLONGATION; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SODIUM RESTRICTION; SYNCOPE; TREATMENT OUTCOME; TREATMENT PLANNING; URINE RETENTION; WELLBEING;

ADRENERGIC AGENTS; ANTI-ARRHYTHMIA AGENTS; CHOLINERGIC ANTAGONISTS; DISOPYRAMIDE; HUMANS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SYNCOPE, VASOVAGAL; THEOPHYLLINE;

EID: 8644225964     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10286-004-1010-4     Document Type: Review

References (36)

1. Alegria JR, Gersh BJ, Scott CG, Hodge DO, Hammill SC, Shen WK (2003) Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 92:82-84
2. Benditt DG, Benson DW Jr, Kreitt J, Dunnigan A, Pritzker MR, Crouse L, Scheinman MM (1983) Electrophysiologic effects of theophylline in young patients with recurrent symptomatic bradyarrhythmias. Am J Cardiol 52: 1223-1229
3. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W (2001) Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1256-1306
4. Brignole M, Gaggioli G, Menozzi C, Gianfranchi L, Bartoletti A, Bottoni N, Lolli G, Oddone D, Del Rosso A, Pellinghelli G (1997) Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing. Circulation 96:3921-3927
5. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227-1230
6. Dietz NM, Engelke KA, Samuel TT, Fix RT, Joyner MJ (1997) Evidence for nitric oxide-mediated sympathetic forearm vasodilatation in humans. J Physiol 498:531-540
7. Dietz NM, Halliwill JR, Spielmann JM, Lawler LA, Papouchado BG, Eickhoff TJ, Joyner MJ (1997) Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol 82:1785-1793
8. Ehringer H (1971) Study of human peripheral hemodynamics after i. v. infusion of a small dosage of dl-1-(2′,5′-dimethoxyphenyl)-2- glycinamidoethanol-(1) hydrochloride (= st 1085). Int Z Klin Pharmakol Ther Toxikol 4: 415-420
9. El-Sayed H, Hainsworth R (1995) Relationship between plasma volume, carotid baroreceptor sensitivity and orthostatic tolerance. Clinical Science 88:463-470
10. El-Sayed H, Hainsworth R (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75: 134-140
11. Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT (2002) Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 40:499-504
12. Jacob G, Robertson D, Mosqueda Garcia R, Ertl AC, Robertson RM, Biaggioni I (1997) Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 103:128-133
13. Kaufmann H, Berman J, Oribe E, Oliver J (1993) Possible increase in the synthesis of endothelial derived relaxing factor (EDRF) during vasovagal syncope. Clin Auton Res 3:69 (Abs)
14. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J (1988) Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 38:951-956
15. Kaufmann H, Saadia D, Voustianiouk A (2002) Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 52: 342-345
16. Lee TM, Su SF, Chen MF, Liau CS, Lee YT (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480-482
17. Lewis T (1932) Lecture on vasovagal syncope and the carotid sinus mechanism. Br Med J 1:873-876
18. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 277: 1046-1051
19. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A, Pena G, Moro C (2001) Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 37:554-559
20. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130:1250-1253
21. Milstein S, Buetikofer J, Lesser J, Goldenberg IF, Benditt DG, Gornick C, Reyes WJ (1989) Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia (see comments). J Am Coll Cardiol 14: 1626-1632
22. Morillo C, Leitch J, Yee R, Klein G (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843-1848
23. Morillo CA, Klein GJ, Gersh BJ (1996) Can serial tilt testing be used to evaluate therapy in neurally mediated syncope? Am J Cardiol 77:521-523
24. Nelson SD, Stanley M, Love CJ, Coyne KS, Schaal SF (1991) The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 151: 2425-2429
25. Oribe E, Kaufmann H, Winters S, Gomes J (1992) Fludrocortisone versus Beta-Adrenergic Blockers in the treatment of vasovagal syncope. Neurology 42:213
26. Pollick C (1995) Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy. Am J Cardiol 75:652
27. Ramsdell CD, Mullen TJ, Sundby GH, Rostoft S, Sheynberg N, Aljuri N, Maa M, Mukkamala R, Sherman D, Toska K, Yelle J, Bloomfield D, Williams GH, Cohen RJ (2001) Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol 90:2245-2248
28. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99:1452-1457
29. Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE (2001) Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 285:52-59
30. Scott WA, Pongiglione G, Bromberg BI, Schaffer MS, Deal BJ, Fish FA, Dick M (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76: 400-402
31. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 78:536-539
32. Sinkovec M, Grad A, Rakovec P (2001) Role of endogenous adenosine in vasovagal syncope. Clin Auton Res 11: 155-161
33. Takata TS, Wasmund SL, Smith ML, Li JM, Joglar JA, Banks K, Kowal RC, Page RL, Hamdan MH (2002) Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 106:1500-1504
34. Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45-49
35. Wieling W, Van Lieshout JJ, Hainsworth R (2002) Extracellular fluid volume expansion in patients with posturally related syncope. Clin Auton Res 12:242-249
36. Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51:120-124